How to upgrade your Eversense Smart
Transmitter
Before you upgrade the firmware on your Smart Transmitter using the Eversense 365 App, you need to do a few important things. These steps will help make sure the upgrade goes smoothly:
NOTE: After Initialization, your system will return to the calibration phase it was in before the upgrade.
Upgrade Notification: When a firmware upgrade is available for your transmitter, you will receive an Upgrade Available Notification on your app.
The system may not be able to begin the firmware upgrade if the transmitter battery is too low, a calibration is in progress, or if the transmitter is disconnected.
NOTE: If your transmitter does not automatically reconnect, see Next Section TRANSMITTER RECONNECT
During some upgrades, you may be prompted to reconnect your transmitter.
IMPORTANT: Before reconnecting, FORGET the transmitter from your device’s Bluetooth settings
When prompted, tap Reconnect Transmitter.
NOTE: Your mobile device must be connected to the internet in order to pair with the smart transmitter.
If you have any questions or need assistance with your firmware upgrade, our Customer Service team is here to help. You can reach us Monday – Sunday, 8am-12am EST at 1-844-736-7348 (844-SENSE4U).
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.